Zevra Therapeutics, Inc. (ZVRA) PT Lowered to $18 at Citizens JMP
Tweet Send to a Friend
Citizens JMP analyst Jason Butler lowered the price target on Zevra Therapeutics, Inc. (NASDAQ: ZVRA) to $18.00 (from $19.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
